Cadila gets USFDA Approval for Generic Drug to Treat Parkinson’s Disease

Cadila gets USFDA Approval for Generic Drug to Treat Parkinson's Disease

Cadila Healthcare announced on December 14, 2017, that they have received approval from the US Food and Drug Administration (FDA) to manufacture Pramipexole Dihydrochloride extended-release tablets, which is used for treatment of Parkinson’s disease.

Parkinson’s disease is a neurodegenerative disorder, which results in to progressive deterioration of motor function due to loss of dopamine-producing brain cells. It is characterized by symptoms such as dementia, depression, and anxiety. According to Parkinson’s Disease Therapeutic Market report published by Coherent Market Insights, there is no proper cure available for the treatment of Parkinson’s disease currently. Treatments options such as medication and surgery to manage the symptoms are available. However, various formulations of drugs such as Pramipexole Dihydrochloride can be effectively used to treat and lower the symptoms of disease.

Zydus Pharmaceuticals (USA) Inc, Cadila Healthcare’s has now received the FDA approval for Pramipexole Dihydrochloride extended-release tablets for treatment of Parkinson’s disease in the American pharmaceutical market.

Pramipexole Dihydrochloride extended-release tablets is available in strengths of 0.375 mg, 0.75 mg, 1.5 mg, 2.25 mg, 3 mg, 3.75 mg, and 4.5 mg. The group also received the final approval from the USFDA to market Nitrofurantoin Capsules USP (macrocrystals), 50 mg and 100 mg, which is indicated to treat acute uncomplicated urinary tract infections. Both the drugs will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad. Shares of Cadila on December 15, 2017 ended 0.34 per cent up at Rs 409.35 on BSE.

Request Sample copy of Parkinson’s Disease Therapeutic Market Report @ https://www.coherentmarketinsights.com/insight/request-sample/494

You may be interested

Negative Pressure Wound Therapy (NPWT) Devices Market Research Report 2018 – Increasing Prevalence Of Chronic Wounds To Fuel The Demand Globally
Healthcare
Healthcare

Negative Pressure Wound Therapy (NPWT) Devices Market Research Report 2018 – Increasing Prevalence Of Chronic Wounds To Fuel The Demand Globally

Mohit Joshi - October 23, 2018

Coherent Market Research Published a Half Cooked Research Report on Global Negative Pressure Wound Therapy (NPWT) Devices Market Research Report. Avail the in-depth table of content Table…

Elbow Lesion Market Research Report 2018 – Rising Number Of Sports Injuries Drives Industry Growth in Near Future
Healthcare
Healthcare

Elbow Lesion Market Research Report 2018 – Rising Number Of Sports Injuries Drives Industry Growth in Near Future

Mohit Joshi - October 23, 2018

Coherent Market Research Published a Half Cooked Research Report on Global Elbow Lesion Market Research Report. Avail the in-depth table of content Table of Content and market…

Deep Brain Stimulation Devices Market Research Report 2018 – Rising Incidence Rate Of Parkinson’S Disease Is Expected To Fuel The Market Growth Till 2024
Healthcare
Healthcare

Deep Brain Stimulation Devices Market Research Report 2018 – Rising Incidence Rate Of Parkinson’S Disease Is Expected To Fuel The Market Growth Till 2024

Mohit Joshi - October 23, 2018

Coherent Market Research Published a Half Cooked Research Report on Global Deep Brain Stimulation Devices Market Research Report. Avail the in-depth table of content Table of Content…

Most from this category